The Evolution of Fourth - Fifth Generation HIV Rapid Test Kits is Booming, the Market to Create USD 2 Billion Opportunities by 2028 - Arizton
17 Jan 2023
The application of fourth-generation and fifth-generation rapid test kits is currently high. The adoption and innovation of digital HIV self-testing tools have increased in recent times, with website-based innovation becoming highly popular.
CHICAGO, Jan. 17, 2023 /PRNewswire/ -- According to Arizton's latest research report, the global HIV rapid test kits market will grow at a CAGR of 2.7% from 2022-2028. HIV rapid test kits have evolved into advanced forms of testing. The application of fourth-generation and fifth-generation rapid test kits is currently high in the market and is expected to become popular in the upcoming years. Fourth-generation HIV test kits are designed to identify HIV antibodies with a blood sample and HIV-specific antigen (p24). Hence, the introduction of fourth-generation HIV kits expects to increase the revenue of the blood sample-based kits in the upcoming years as their acceptance is likely to increase. Older-generation HIV test kits, such as third-generation HIV test kits, are unreliable until three months after exposure to HIV. Hence, these limitations increase the demand for fourth-generation HIV rapid test kits globally.
Continue Reading
Preview
Source: PRNewswire
HIV Rapid Test Kits Market
Moreover, the introduction of digital support for HIV self-testing and government initiatives to boost the sales of the market. The application of digital tools in HIV management is increasing rapidly, which is expected to fuel the adoption of HIV self-testing rapid test kits. These interventions are currently improving HIV care and diagnosis. In 2021–2022, the HIV Self-Testing (HIVST) deployment and digital tool integrations in health services were emerging, but it was a priority for UNAIDS. In healthcare services, digital health technologies are achieving high traction in high-and middle-income countries. Furthermore, telemedicine has allowed the continuity of HIV care for many patients. The COVID-19 pandemic covers the roadmap for the evolution of HIV self-testing with digital support to reduce the gap in HIV care deliveries. . The application of digital tools in HIV management is increasing rapidly, which is expected to fuel the adoption of HIV self-testing rapid test kits. These interventions are currently improving HIV care and diagnosis. In 2021–2022, the HIV Self-Testing (HIVST) deployment and digital tool integrations in health services were at an emerging stage, but it was a priority for UNAIDS. In healthcare services, digital health technologies are achieving high traction in high-and middle-income countries. Furthermore, telemedicine has allowed the continuity of HIV care for many patients. The COVID-19 pandemic covers the roadmap for the evolution of HIV self-testing with digital support to reduce the gap in HIV care deliveries.
Implementing digital tools in the HIV rapid test kits market has a high potential to reach diverse audiences with the potential for widespread scale-up. The effective and efficient linkage between health services and patients increasing access to HIV testing. These factors are expected to increase HIV rapid test adoption in the diverse patient population, thereby driving the demand for market growth in upcoming years. According to the Lancet, the adoption and innovation of digital HIV self-testing tools have increased in recent times, with website-based innovation becoming highly popular. Around 54% of HIV self-testing digital tool innovations are related to website-based innovations based on studies run by the Lancet. These studies are conducted in Asia, North America, Europe, South America, and Africa. Digital tools support in HIVST have been acceptable, feasible, and preferable in the last decades, however, they are currently showing uptake, with improvement in the access to HIV rapid test kits and associated clinical outcomes.
Global HIV Rapid Test Kits Market Report Scope
Click Here to Download the Free Sample Report
North America, APAC, Middle East & Africa, Europe, and Latin America are the major geographies covered in the global HIV rapid test kits market. In 2022, North America accounted for a 31.06% share of the global HIV rapid test kits market and dominated it with high revenue generation. The factors propelling the market growth in the region are high HIV prevalence and increasing awareness of the disease. In addition, government-backed programs and initiatives for HIV self-testing support the market growth in the region. APAC and Middle East Africa regions expect to offer lucrative market growth opportunities during the forecast period.
According to the Lancet, the adoption and innovation of digital HIV self-testing tools have increased in recent times, with website-based innovation becoming highly popular. Around 54% of HIV self-testing digital tool innovations are related to website-based innovations based on studies run by the Lancet. These studies are conducted in Asia, North America, Europe, South America, and Africa. Digital tools support in HIVST have been acceptable, feasible, and preferable in the last decades, however, they are currently showing uptake, with improvement in the access to HIV rapid test kits and associated clinical outcomes. Some companies collaborating with the WHO and UNAIDS to increase the rate of HIV self-testing, thereby supporting HIV rapid test kits market growth. In 2022, the WHO partnered with the Clinton Health Access Initiative (CHAI), Wondfo Biotech Company, and MedAccess. These partnerships make available HIV-self-test kits for only $1 in the public sector in LMICs. This is expected to increase the high market competition among leading market players. Inorganic growth strategies by leading market players have creating entry barriers for many small and emerging players.
ADOPTION OF INNOVATION LATERAL FLOW IMMUNOASSAY IS HIGH ACROSS HIV RAPID TEST KITS MARKET
Several companies in the market are coming up with low-cost lateral flow-based HIV test kits. Many regulatory bodies, such as the WHO and other NGOs, are funding HIV test kit manufacturing. This will help companies to come up with unique products in the market. The level of innovations in the lateral flow immune assay is high in the market. In LMICs, there is a constant rise in the prevalence of HIV infection, which demands the usage of HIV rapid diagnostic test kits to increase significantly. Lateral flow immune assays are more user-friendly and are highly used among people with limited access to healthcare settings. Most health authorities and healthcare settings suggest immunochromatographic rapid test kits. In western African countries, the newly developed and available HIV rapid test kits, which are developed based on the immunochromatographic assay, are commonly used. Market players expect to have high market growth opportunities in Africa.
Click Here to Download the Free Sample Report
KEY COMPANY PROFILES
Abbott
BIOMÉRIEUX
AccuBioTech
Cupid Limited
DIALAB
HUMAN
INTEC
Nanjing Synthgene Medical Technology
SD Biosensor
Türklab A.S.
MARKET SEGMENTATION
Technology
Lateral Flow Immunoassay
Immunofiltration
Sample Type
Blood
Oral Fluid
Urine
Distribution Channels
Offline
Online
Geography
North America
US
Canada
Europe
France
Italy
Ukraine
Portugal
Russia
APAC
China
India
Indonesia
Thailand
Vietnam
Latin America
Brazil
Mexico
Columbia
Middle East & Africa
South Africa
Mozambique
Kenya
Nigeria
Tanzania
CHECK OUT SOME OF THE TOP-SELLING RESEARCH RELATED REPORTS
Fertility Test Market - Global Outlook & Forecast 2022-2027: The global fertility test market is expected to reach USD 659.71 million by 2027. The global fertility treatment is presumably to grow at a healthy rate due to attractive long-term growth from favorable demographic and social/cultural shifts. Fertility testing is a niche industry with high margins for manufacturers, especially for vendors offering kits, which males and females widely use.
Lateral Flow Assays Market - Global Outlook & Forecast 2023-2028: The global lateral flow assays market is expected to reach USD 11.30 billion by 2028. The market is one of the major segments in the global point of care or the rapid diagnostics market and is growing steadily and is anticipated to grow at a similar pace during the forecast period. Further, the growth in the market is attributed to the increasing prevalence/incidence of various infectious and chronic diseases. In addition, malaria is still a cause of death in a few regions. For instance, according to the WHO, malaria is one of the leading causes of death in the Middle East & Africa.
COVID-19 Rapid Antigen Test Kits Market - Global Outlook & Forecast 2022-2027: The COVID-19 rapid antigen tests market is expected to reach $743.07 million by 2027. Antigen tests are commonly used in the diagnosis of pathogens, including influenza viruses and respiratory syncytial viruses. These tests are immunoassays that detect specific viral antigen and confirms the presence or absence of viral infection. Rapid antigen tests are currently authorized to be performed on nasal or nasopharyngeal swab specimens placed directly into the immunoassay's extraction buffer or reagent. The currently available rapid antigen tests include point-of-care (POC) and laboratory-based tests, as well as self-tests performed at home, and they are commercially available to people of any age.
DNA Extraction Kit Market – Global Outlook & Forecast 2022-2027: The DNA extraction kit market size is expected to reach USD 2.1 billion by 2027. North America dominated the DNA extraction kit market share. However, APAC is expected to grow at a faster rate, with a CAGR of over 9% in the DNA extraction market. The increasing investments in genome sequencing, increasing adoption of genetic testing-based diagnostics for rare diseases, oncology, and higher adoption of personalized medicines are largely driving the North America Market.
WHY ARIZTON?
100% Customer Satisfaction
24x7 availability – we are always there when you need us
200+ Fortune 500 Companies trust Arizton's report
80% of our reports are exclusive and first in the industry
100% more data and analysis
5+ years of experience in delivering Insights at the Global, Regional & Country Level
TABLE OF CONTENT
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET BY TECHNOLOGY
4.3.2 MARKET BY SAMPLE TYPE
4.3.3 MARKET BY DISTRIBUTION CHANNELS
4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 PREMIUM INSIGHTS
7.1 OVERVIEW
8 INTRODUCTION
8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
9.1 INTRODUCTION OF NEXT GENERATION HIV RAPID TEST KITS
9.2 INCREASE IN HIV SELF-TESTING BY GOVERNMENT BODIES
9.3 DIGITAL SUPPORT FOR HIV SELF-TESTING
10 MARKET GROWTH ENABLERS
10.1 INCREASING HIV PATIENT POPULATION
10.2 INCREASED RESOURCES AVAILABILITY AND FUNDING FOR HIV MANAGEMENT
10.3 INCREASED AWARENESS OF HIV SELF-TESTING
11 MARKET RESTRAINTS
11.1 INCREASING INCIDENCES OF FALSE NEGATIVES
11.2 LIMITATIONS & CHALLENGES ASSOCIATED WITH HIV TESTING
11.3 LOW ACCESSIBLITY & LACK OF AWARENESS FOR HIVST
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.1.1 INSIGHTS BY TECHNOLOGY
12.1.2 INSIGHTS BY SAMPLE TYPE
12.1.3 INSIGHTS BY DISTRIBUTION CHANNELS
12.1.4 INSIGHTS BY GEOGRAPHY
12.2 MARKET SIZE & FORECAST
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 TECHNOLOGY
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 LATERAL FLOW IMMUNOASSAY
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 IMMUNOFILTRATION
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
14 SAMPLE TYPE
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 BLOOD
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 ORAL FLUID
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 URINE
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
15 DISTRIBUTION CHANNEL
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 OFFLINE
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 ONLINE
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
16 GEOGRAPHY
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 GEOGRAPHIC OVERVIEW
17 NORTH AMERICA
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 TECHNOLOGY
17.3.1 MARKET SIZE & FORECAST
17.4 SAMPLE TYPE
17.4.1 MARKET SIZE & FORECAST
17.5 DISTRIBUTION CHANNELS
17.5.1 MARKET SIZE & FORECAST
17.6 KEY COUNTRIES
17.6.1 US: MARKET SIZE & FORECAST
17.6.2 CANADA: MARKET SIZE & FORECAST
18 APAC
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 TECHNOLOGY
18.3.1 MARKET SIZE & FORECAST
18.4 SAMPLE TYPE
18.4.1 MARKET SIZE & FORECAST
18.5 DISTRIBUTION CHANNELS
18.5.1 MARKET SIZE & FORECAST
18.6 KEY COUNTRIES
18.6.1 CHINA: MARKET SIZE & FORECAST
18.6.2 INDIA: MARKET SIZE & FORECAST
18.6.3 INDONESIA: MARKET SIZE & FORECAST
18.6.4 THAILAND: MARKET SIZE & FORECAST
18.6.5 VIETNAM: MARKET SIZE & FORECAST
19 MIDDLE EAST & AFRICA
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 TECHNOLOGY
19.3.1 MARKET SIZE & FORECAST
19.4 SAMPLE TYPE
19.4.1 MARKET SIZE & FORECAST
19.5 DISTRIBUTION CHANNELS
19.5.1 MARKET SIZE & FORECAST
19.6 KEY COUNTRIES
19.6.1 SOUTH AFRICA: MARKET SIZE & FORECAST
19.6.2 MOZAMBIQUE: MARKET SIZE & FORECAST
19.6.3 KENYA: MARKET SIZE & FORECAST
19.6.4 NIGERIA: MARKET SIZE & FORECAST
19.6.5 TANZANIA: MARKET SIZE & FORECAST
20 EUROPE
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 TECHNOLOGY
20.3.1 MARKET SIZE & FORECAST
20.4 SAMPLE TYPE
20.4.1 MARKET SIZE & FORECAST
20.5 DISTRIBUTION CHANNELS
20.5.1 MARKET SIZE & FORECAST
20.6 KEY COUNTRIES
20.6.1 FRANCE: MARKET SIZE & FORECAST
20.6.2 ITALY: MARKET SIZE & FORECAST
20.6.3 UKRAINE: MARKET SIZE & FORECAST
20.6.4 PORTUGAL: MARKET SIZE & FORECAST
20.6.5 RUSSIA: MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 TECHNOLOGY
21.3.1 MARKET SIZE & FORECAST
21.4 SAMPLE TYPE
21.4.1 MARKET SIZE & FORECAST
21.5 DISTRIBUTION CHANNELS
21.5.1 MARKET SIZE & FORECAST
21.6 KEY COUNTRIES
21.6.1 BRAZIL: MARKET SIZE & FORECAST
21.6.2 MEXICO: MARKET SIZE & FORECAST
21.6.3 COLOMBIA: MARKET SIZE & FORECAST
22 COMPETITIVE LANDSCAPE
22.1 COMPETITION OVERVIEW
22.2 MARKET SHARE ANALYSIS
22.2.1 ABBOTT
22.2.2 BIO-RAD LABORATORIES
22.2.3 BIOMÉRIEUX
22.2.4 CHEMBIO DIAGNOSTICS
22.2.5 ORASURE TECHNOLOGIES
23 KEY COMPANY PROFILES
23.1 ABBOTT
23.1.1 BUSINESS OVERVIEW
23.1.2 PRODUCT OFFERINGS
23.1.3 KEY STRATEGIES
23.1.4 KEY STRENGTHS
23.1.5 KEY OPPORTUNITIES
23.2 BIO-RAD LABORATORIES
23.3 BIOMÉRIEUX
23.4 CHEMBIO DIAGNOSTICS
23.5 ORASURE TECHNOLOGIES
24 OTHER PROMINENT VENDORS
24.1 ATOMO DIAGNOSTICS
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.2 ACCUBIOTECH
24.3 BIOLYTICAL LABORATORIES
24.4 BIOSYNEX
24.5 CUPID LIMITED
24.6 HUMAN
24.7 INTEC
24.8 J. MITRA & CO
24.9 MERIL LIFE SCIENCES
24.10 MP BIOMEDICALS
24.11 MEDSOURCE OZONE BIOMEDICALS
24.12 NANJING SYNTHGENE MEDICAL TECHNOLOGY
24.13 PREMIER MEDICAL
24.14 SD BIOSENSOR
24.15 KHB (SHANGHAI KEHUA BIO-ENGINEERING)
24.16 TÜRKLAB A.S.
24.17 TRINITY BIOTECH
24.18 WANTAI BIOPHARMA
24.19 WONDFO
25 REPORT SUMMARY
25.1 KEY TAKEAWAYS
25.2 STRATEGIC RECOMMENDATIONS
26 QUANTITATIVE SUMMARY
26.1 MARKET BY GEOGRAPHY
26.2 MARKET BY TECHNOLOGY
26.3 MARKET BY SAMPLE TYPE
26.4 MARKET BY DISTRIBUTION CHANNELS
26.5 TECHNOLOGY: MARKET BY GEOGRAPHY
26.5.1 LATERAL FLOW IMMUNOASSAY: MARKET BY GEOGRAPHY
26.5.2 IMMUNOFILTRATION: MARKET BY GEOGRAPHY
26.6 SAMPLE TYPE: MARKET BY GEOGRAPHY
26.6.1 BLOOD SAMPLE TYPE: MARKET BY GEOGRAPHY
26.6.2 ORAL FLUID SAMPLE TYPE: MARKET BY GEOGRAPHY
26.6.3 URINE SAMPLE TYPE: MARKET BY GEOGRAPHY
26.7 DISTRIBUTION CHANNELS: MARKET BY GEOGRAPHY
26.7.1 OFFLINE DISTRIBUTION CHANNELS: MARKET BY GEOGRAPHY
26.7.2 ONLINE DISTRIBUTION CHANNELS: MARKET BY GEOGRAPHY
27 APPENDIX
27.1 ABBREVIATIONS
About
Us
:
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Click Here to Contact Us
Call: +1-312-235-2040
+1 302 469 0707
Mail: [email protected]
Photo: https://mma.prnewswire.com/media/1984906/HIV_Rapid_Tests_Kit_Market.jpg
Logo: https://mma.prnewswire.com/media/818553/Arizton_Logo.jpg
SOURCE Arizton Advisory & Intelligence
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.